⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRDF News
Cardiff Oncology, Inc. Common Stock
Cardiff Oncology to Participate in Three Upcoming Investor Conferences
globenewswire.com
CRDF
Form 8-K
sec.gov
CRDF
Form 8-K
sec.gov
CRDF
Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
globenewswire.com
CRDF
Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
CRDF
Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC
globenewswire.com
CRDF
Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development
globenewswire.com
CRDF
CTMX
Global Polymer-Based Solubility Enhancement Excipients Market Forecast 2031: Strong CAGR of 13.1% Fueled by Pharmaceutical Innovation | Valuates Reports
prnewswire.com
AMPH
CRDF
LLY
MRK
PFE
REGN
XBI
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
globenewswire.com
ONCY
AGEN
CRDF
EXEL
GILD
Sidoti Events, LLC's Year-End Virtual Investor Conference
accessnewswire.com
CRGO
NNOX
WDH
ICFI
FSTR
MNY
VPG
PRE
CRAI
IHRT
OIS
GRC
DRTS
KOP
FFAI
GAIA
ROCK
MTRX
ACIC
MG
CIA
MEHA
SINT
BODI
BAER
OPRT
COE
GATX
KELYA
PANL
PAR
PLXS
UIS
EVAX
DTIL
OWLS
LRE
USNA
IRIX
LZM
CNXN
FIX
XBP
STRT
FBIZ
MPTI
TOMZ
ABL
SBC
HRTG
CRDF
INV
RAIL
MGRC
OSPN
SRTA
SRTAW